Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
David C. ParkeManaging Director
David Parke joined Burrill & Company in June 2011 as a managing director of Burrill Merchant Banking. Mr. Parke specializes in public offerings, private placements, fairness opinions, and mergers and acquisitions for emerging-growth companies. His experience delivers a strong background in capital markets with an in-depth understanding of the issues particular to life sciences and healthcare companies.
Mr. Parke joined Burrill & Company from Boenning & Scattergood. Prior to that, he was with Mufson Howe Hunter & Company for three years, where he was instrumental in launching and developing the firm's emerging growth practice. He was previously with the corporate finance department of Investec, Inc. and its predecessor, Pennsylvania Merchant Group. Mr. Parke has managed or participated in 40 public offerings and private placements, raising more than $1 billion for emerging growth clients. In addition, he has managed mergers and acquisitions assignments ranging from $5 million to $500 million. Prior to joining Investec in 1992, he was in the corporate finance departments of Wheat First Butcher & Singer, now Wachovia Securities, and Legg Mason.
He has been a director of Petroleum Development Corporation, a publicly-traded natural gas exploration and production company, since 2003. He chairs the board's Finance and Planning Committee, and is a member of its Compensation and Audit Committees.
Mr. Parke received his MBA with Honors from The Wharton School of the University of Pennsylvania, and graduated summa cum laude and Phi Beta Kappa from Lehigh University with a B.S. in Finance.